

Cefepime is a fourth-generation IV cephalosporin antibiotic. Learn what it treats, how it's dosed, who should avoid it, and what it costs in 2026.
Cefepime is a fourth-generation cephalosporin antibiotic given intravenously (IV) or intramuscularly (IM) to treat serious bacterial infections including pneumonia, urinary tract infections, and febrile neutropenia.
Originally sold under the brand name Maxipime by Bristol-Myers Squibb, Cefepime is now available almost exclusively as a generic. It belongs to the beta-lactam class of antibiotics and is particularly effective against gram-negative bacteria, including Pseudomonas aeruginosa — a notoriously difficult-to-treat pathogen.
Multiple manufacturers produce generic Cefepime, including Apotex, Hospira/Pfizer, Sagent, BBraun, Baxter, and Eugia/Dr. Reddy's. It is not a controlled substance and does not have a DEA schedule.
Cefepime is FDA-approved for treating several types of serious infections:
Doctors also prescribe Cefepime for conditions not on its official label, based on clinical evidence and guidelines:
Cefepime is not available as a pill or liquid you take by mouth. It must be given by a healthcare professional through one of two routes:
You'll receive Cefepime in one of these settings:
The standard dose ranges from 1 to 2 g every 8-12 hours, depending on the type and severity of infection:
Kidney function matters: If your creatinine clearance is below 60 mL/min, your dose must be reduced. Cefepime is removed by hemodialysis, so patients on dialysis need supplemental doses after each session.
Cefepime should not be used if you have:
Special caution is needed for:
For more on risks, see our detailed guide on Cefepime side effects.
Because Cefepime is a generic injectable antibiotic, pricing varies by setting:
There are no manufacturer copay cards or savings programs since Maxipime is largely discontinued and Cefepime is only available as a generic. However, hospital financial assistance programs and patient assistance through organizations like NeedyMeds and RxAssist may help qualifying patients.
Cefepime is a critical antibiotic for treating some of the most serious bacterial infections, from hospital-acquired pneumonia to neutropenic fever in cancer patients. While it's only available as an injection — meaning it requires a healthcare setting or home IV setup — it remains one of the most effective tools against resistant gram-negative bacteria.
If you've been prescribed Cefepime and are having difficulty finding it due to the current shortage, use Medfinder to check availability near you, or talk to your doctor about alternative options.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.